Starting Imatinib at 400 mg Daily in Patients with Gastrointestinal Stromal Tumors Harboring KIT Exon 9 Mutations: A Retrospective, Multicenter Study

  1. Callejo, A.
  2. Faouzi, S.
  3. Bouché, O.
  4. Bertucci, F.
  5. Chevalier, T.
  6. Isambert, N.
  7. Duffaud, F.
  8. Collard, O.
  9. Penel, N.
  10. Terrier, P.
  11. Mir, O.
  12. Blay, J.Y.
  13. Le Cesne, A.
Aldizkaria:
Targeted Oncology

ISSN: 1776-260X 1776-2596

Argitalpen urtea: 2021

Alea: 16

Zenbakia: 4

Orrialdeak: 485-492

Mota: Artikulua

DOI: 10.1007/S11523-021-00820-7 GOOGLE SCHOLAR